[{"address1": "3160 Porter Drive", "address2": "Suite 250", "city": "Palo Alto", "state": "CA", "zip": "94304", "country": "United States", "phone": "650 391 9740", "website": "https://bridgebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. Its products in development programs include AG10, a next-generation oral small molecule near-complete TTR stabilizer that is in Phase 3 clinical trial for the treatment of TTR amyloidosis, or transthyretin amyloid cardiomyopathy (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 double-blinded, placebo-controlled pivotal study for the treatment option for children with achondroplasia; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 1/2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 3 clinical trial for treating autosomal dominant hypocalcemia type 1, or ADH1; and BBP-418, a glycosylation substrate pro-drug that is in Phase 3 clinical trial for treating limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). In addition, it engages in developing products for mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Neil  Kumar Ph.D.", "age": 44, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 1534840, "exercisedValue": 0, "unexercisedValue": 51135260}, {"maxAge": 1, "name": "Dr. Charles J. Homcy M.D.", "age": 76, "title": "Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 563200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank P. McCormick Ph.D.", "age": 74, "title": "Co-Founder, Chairman of Oncology & Director", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 542778, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian C. Stephenson C.F.A., Ph.D.", "age": 43, "title": "CFO & Secretary", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 1151240, "exercisedValue": 0, "unexercisedValue": 16193392}, {"maxAge": 1, "name": "Dr. Richard H. Scheller Ph.D.", "age": 71, "title": "Chairman of Research & Development", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 509622, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas  Trimarchi Ph.D.", "title": "President & COO", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uma  Sinha Ph.D.", "age": 66, "title": "Chief Scientific Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 1313457, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eli M. Wallace Ph.D.", "age": 57, "title": "Chief Scientific Officer of Oncology", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eric Michael David J.D., M.D., Ph.D.", "age": 52, "title": "Chief Executive Officer of Gene Therapy", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Outten CPC, MBA", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 36.805, "open": 37.94, "dayLow": 36.385, "dayHigh": 38.05, "regularMarketPreviousClose": 36.805, "regularMarketOpen": 37.94, "regularMarketDayLow": 36.385, "regularMarketDayHigh": 38.05, "payoutRatio": 0.0, "forwardPE": -12.042483, "volume": 2383224, "regularMarketVolume": 2383224, "averageVolume": 2676425, "averageVolume10days": 2839570, "averageDailyVolume10Day": 2839570, "bid": 36.74, "ask": 36.92, "bidSize": 1, "askSize": 1, "marketCap": 6964281344, "fiftyTwoWeekLow": 21.62, "fiftyTwoWeekHigh": 39.47, "priceToSalesTrailing12Months": 31.384491, "fiftyDayAverage": 31.5102, "twoHundredDayAverage": 27.59625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8032019968, "profitMargins": -2.4144099, "floatShares": 132250064, "sharesOutstanding": 188990000, "sharesShort": 18776419, "sharesShortPriorMonth": 19299148, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0994, "heldPercentInsiders": 0.02917, "heldPercentInstitutions": 0.94953, "shortRatio": 6.67, "shortPercentOfFloat": 0.1525, "impliedSharesOutstanding": 188990000, "bookValue": -7.749, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -535761984, "trailingEps": -2.88, "forwardEps": -3.06, "enterpriseToRevenue": 36.196, "enterpriseToEbitda": -14.059, "52WeekChange": 0.08249998, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 36.85, "targetHighPrice": 95.0, "targetLowPrice": 36.4, "targetMeanPrice": 52.09333, "targetMedianPrice": 49.0, "recommendationMean": 1.64706, "recommendationKey": "buy", "numberOfAnalystOpinions": 15, "totalCash": 681100992, "totalCashPerShare": 3.595, "ebitda": -571292992, "totalDebt": 1730584064, "quickRatio": 5.069, "currentRatio": 5.327, "totalRevenue": 221902000, "revenuePerShare": 1.193, "returnOnAssets": -0.49238998, "grossProfits": 221902000, "freeCashflow": -427052256, "operatingCashflow": -520726016, "revenueGrowth": 2.371, "grossMargins": 1.0, "ebitdaMargins": -2.5745301, "operatingMargins": -37.62904, "financialCurrency": "USD", "symbol": "BBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1740171903, "regularMarketTime": 1740171600, "exchange": "NMS", "messageBoardId": "finmb_412911458", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.122261025, "regularMarketPrice": 36.85, "marketState": "POST", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1561642200000, "postMarketChangePercent": 0.0, "postMarketPrice": 36.85, "postMarketChange": 0.0, "regularMarketChange": 0.04499817, "regularMarketDayRange": "36.385 - 38.05", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2676425, "fiftyTwoWeekLowChange": 15.229998, "fiftyTwoWeekLowChangePercent": 0.7044402, "fiftyTwoWeekRange": "21.62 - 39.47", "fiftyTwoWeekHighChange": -2.6200027, "fiftyTwoWeekHighChangePercent": -0.0663796, "fiftyTwoWeekChangePercent": 8.249998, "earningsTimestamp": 1740054600, "earningsTimestampStart": 1746016200, "earningsTimestampEnd": 1746448200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.88, "epsForward": -3.06, "epsCurrentYear": -3.66099, "priceEpsCurrentYear": -10.065583, "fiftyDayAverageChange": 5.339798, "fiftyDayAverageChangePercent": 0.16946252, "twoHundredDayAverageChange": 9.253748, "twoHundredDayAverageChangePercent": 0.33532628, "priceToBook": -4.755452, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "shortName": "BridgeBio Pharma, Inc.", "longName": "BridgeBio Pharma, Inc.", "displayName": "BridgeBio Pharma", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]